Back
Pliant Therapeutics Vs. Akero Therapeutics Industry Stock Comparison
Sell
30
PLRX
Pliant Therapeutics
Last Price:
$1.36
Seasonality Move:
44.98%
Buy
60
AKRO
Akero Therapeutics
Last Price:
$55.77
Seasonality Move:
13.24%
Sell
30
Pliant Therapeutics (PLRX)
is a Sell
Is Pliant Therapeutics a Buy, Sell or Hold?
-
The current Pliant Therapeutics [PLRX] share price is $1.38. The Score for PLRX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
PLRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $55.75. The Score for AKRO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PLRX Stock Price Chart
What is Pliant Therapeutics's stock price today?
-
The Pliant Therapeutics share price today is $1.38Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing slight selling pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $55.75Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
PLRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 42.48 | Sell |
Chaikin Money Flow: | -368030 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.25 | Buy |
Relative Strength Index (14 RSI): | 69.65 | Buy |
Chaikin Money Flow: | 1465917 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.46 - 54.12) | Buy |
Bollinger Bands (100): | (37.99 - 51.97) | Buy |
PLRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.54 | Sell |
20-day SMA: | 1.44 | Sell |
50-day SMA: | 1.44 | Sell |
200-day SMA: | 8.15 | Sell |
8-day EMA: | 1.48 | Sell |
20-day EMA: | 1.47 | Sell |
50-day EMA: | 1.85 | Sell |
200-day EMA: | 6.61 | Sell |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.42 | Buy |
20-day SMA: | 50.45 | Buy |
50-day SMA: | 44.07 | Buy |
200-day SMA: | 36.94 | Buy |
8-day EMA: | 53.99 | Buy |
20-day EMA: | 50.85 | Buy |
50-day EMA: | 46.7 | Buy |
200-day EMA: | 38.73 | Buy |
Pliant Therapeutics Earnings Growth & PLRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.50 per share, a decrease next quarter of $0.13 per share, an increase this year of $1.09 per share, and an increase next year of $0.08 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
Pliant Therapeutics Technical Analysis
Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |